RE: Agree with this16 May 2018 11:46
For all that you say, the simple fact is:
Big pharma joins and share price will take off
No pharma joins, IMM cannot afford to take this on all by itself and share plummets.
This is a speculative share, it all comes down to whether the detailed data shows that the risk reward is there for a big pharma to invest a lot of time and money in this. There is a market out there for Lupuzor but if the detailed data can't explain why the placebo did so well then I find it unlikely a pharma would take it on. Then again, if a pharma does this share price will go into multiplies. I for one have the opinion they will be able to explain away the placebo issue.